Senior insider sale
Head of R&D, CMO at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$1.18M
65.52K shares
What this filing means
BOTWOOD NICHOLAS A.J. plans to sell 65.52K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $1.18M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/12/2026ACC: 0001959173-26-004618
Officer· Head of R&D, CMO
Since Feb 2026
65.52K
Shares to sell
$1.18M
Approx. market value
31.23K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
6/12/2026
31.23KTotal acquired31.23K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/12/2026 | Stock Option Exercise Cash | 31.23K | — |
| Total | 31.23K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
34.28K
Market value
$609.4K
6/11/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
31.23K
Market value
$566.7K
6/12/2026
Total
Units
65.52K
Value
$1.18M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/11/2026 | 34.28K | $609.4K | — | Completed |
| Planned — Approximate Date | ||||
6/12/2026 | 31.23K | $566.7K | NASDAQ | Planned |
| Total | 65.52K | $1.18M | ||